Metraipolis › archive › dc_32637e6fe85f

Determinants of survival in patients treated with CPX-351 for acute myeloid leukemia — Europe PMC PMID:42125699

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125699
DOI
10.3389/fonc.2026.1813333
License (as archived)
solo-consultazione
Archived
2026-11-03T03:15:51.379Z
SHA-256 of the archived text
4d9b4d780af43612333236ab2e9f078c5a16e865bdfe8d34450094e1bbfb2f23
Stable URL of this page
https://metraipolis.com/documento/dc_32637e6fe85f

How to cite

Determinants of survival in patients treated with CPX-351 for acute myeloid leukemia — Europe PMC PMID:42125699 — Europe PMC (en), https://europepmc.org/article/MED/42125699 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32637e6fe85f (Metraipolis archive dc_32637e6fe85f, sha256 4d9b4d780af43612333236ab2e9f078c5a16e865bdfe8d34450094e1bbfb2f23)
BibTeX
@misc{dc32637e6fe85f,
  title = {Determinants of survival in patients treated with CPX-351 for acute myeloid leukemia — Europe PMC PMID:42125699},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125699},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32637e6fe85f; sha256 4d9b4d780af43612333236ab2e9f078c5a16e865bdfe8d34450094e1bbfb2f23},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125699. Agents can read the archived copy with the MCP tool read_document.